Preventing falls in Parkinson’s disease by re-educating reactive and planned foot placement accuracy through a multi-sensory approach. 3 cases.
Objective: To demonstrate a novel approach to preventing falls in Parkinson’s disease (PD) that improves anticipatory postural adjustments facilitating a more accurate moving base of…The impact of gender identity and gender role orientation on health-related quality of life in people with Parkinson’s disease.
Objective: To assess the associations of gender identity and gender role orientation with health-related quality of life (HRQoL) among persons with Parkinson’s disease (PD). Background:…The Gastrointestinal Dysfunction Scale – Parkinson’s Disease (GIDS-PD): a new tool to assess gastrointestinal dysfunction in Parkinson’s Disease
Objective: Objective: To develop and validate the Gastrointestinal Dysfunction Scale – Parkinson’s Disease (GIDS-PD), a self-report scale designed to assess presence and severity of Gastrointestinal…Impact of device-aided therapies on QoL and Off-time improvement in advanced Parkinson’s Disease patients: Comparative effectiveness results from a Bayesian Network Meta-Analysis
Objective: To compare off-time and QoL changes among APD patients taking LCIG, DBS, CSAI, and BMT at 6 months after therapy initiation. Background: Advanced Parkinson’s…Deep Brain Stimulation of Anterior Globus Pallidus internus Reduces Impulsivity in Parkinson’s Disease
Objective: To evaluate whether selective deep brain stimulation (DBS) stimulation of anterior region of globus pallidus internus (GPi) affects impulsivity in Parkinson’s Disease patients Background:…Comparison of video-instructed and operator-instructed markerless motion analysis with clinical rating-scales in patients with Parkinson’s Disease
Objective: This study aims to compare video-instructed and operator-instructed RGB-Depth (RGBD) camera assessments with clinical ratings scales for gait and balance in patients with Parkinson’s Disease…Multimodal Conversational AI for Remote Patient Monitoring and Analysis of Parkinson’s Disease
Objective: To present, analyze and evaluate a cloud-based audio-visual dialog agent and its associated automated speech, face and movement analytics for remote patient monitoring in…Homeostatic Improvement of Brain Bioenergetic Metabolism in Parkinson’s Disease: Results From A Phase 2 REPAIR-PD Clinical Trial With CNM-Au8
Objective: To determine the effects of the nanocatalytic drug, CNM-Au8, on brain energy metabolites in Parkinson’s Disease. Background: Converging lines of evidence are identifying brain…Application of the updated MDS criteria for prodromal Parkinson’s disease to a population-based 10-year study
Objective: We aimed to identify differences and analyze the potential added value of the updated Movement Disorders Society (MDS) research criteria for prodromal Parkinson’s disease…The Development of a Parkinson’s Disease Biomarker Inventory Dashboard
Objective: There is an urgent need for validated biofluid biomarkers in Parkinson’s disease (PD) drug development. Under the auspices of the Critical Path for Parkinson’s…
- « Previous Page
- 1
- …
- 280
- 281
- 282
- 283
- 284
- …
- 338
- Next Page »